Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 9/20 | 0.41 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.39 |
| ▸ | ACKR3 | P25106 | 2/20 | 0.39 |
| ▸ | CDK9 | P50750 | 1/20 | 0.38 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL627262 | 0.87 | CCNA2 (0.48) | GPR119ACKR3CCNA2CDK2 | |
| SCHEMBL627340 | 0.86 | NAMPT (0.49) | NAMPTGPR119ACKR3CYP2C9 | |
| SCHEMBL628406 | 0.81 | CYP11B2 (0.44) | GPR119ACACB | |
| SCHEMBL625492 | 0.81 | NAMPT (0.39) | NAMPTGPR119ACKR3CCNA2CDK2 | |
| SCHEMBL627266 | 0.81 | CYP11B2 (0.41) | GPR119ACACB | |
| SCHEMBL625243 | 0.80 | FYN (0.60) | NAMPTCDK9 | |
| SCHEMBL623828 | 0.80 | FYN (0.46) | CDK9CCNA2CDK2 | |
| SCHEMBL624036 | 0.80 | FYN (0.46) | GPR119CDK9 | |
| SCHEMBL625407 | 0.80 | PIK3CA (0.45) | NAMPTCDK9 | |
| SCHEMBL625495 | 0.79 | PIM1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012020217-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |